Goldman upgraded HealthEquity from Sell to Neutral and set a new price target of $77.00 from $64.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/15/2024 | $108.00 | Neutral | Goldman |
| 4/4/2024 | $101.00 | Mkt Outperform | JMP Securities |
| 4/2/2024 | $86.00 → $108.00 | Overweight | JP Morgan |
| 1/3/2024 | $84.00 | Overweight | Barclays |
| 9/21/2023 | $79.00 → $87.00 | Neutral → Outperform | Robert W. Baird |
| 10/21/2022 | $64.00 → $77.00 | Sell → Neutral | Goldman |
| 9/16/2022 | $85.00 | Overweight | KeyBanc Capital Markets |
| 7/12/2022 | $59.00 | Sell | Goldman |
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
HealthEquity (NASDAQ:HQY) has outperformed the market over the past 10 years by 4.88% on an annualized basis producing an average annual return of 15.82%. Currently, HealthEquity has a market capitalization of $6.56 billion. Buying $100 In HQY: If an investor had bought $100 of HQY stock 10 years ago, it would be worth $434.18 today based on a price of $75.44 for HQY at the time of writing. HealthEquity's Performance Over Last 10 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine a
HealthEquity (NASDAQ:HQY) has outperformed the market over the past 10 years by 4.89% on an annualized basis producing an average annual return of 15.9%. Currently, HealthEquity has a market capitalization of $6.66 billion. Buying $100 In HQY: If an investor had bought $100 of HQY stock 10 years ago, it would be worth $437.38 today based on a price of $76.49 for HQY at the time of writing. HealthEquity's Performance Over Last 10 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine an
HealthEquity's (NYSE:HQY) short percent of float has risen 4.55% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 4.6% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.85 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interest is
DRAPER, Utah, Nov. 12, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced that after leading the company for more than 15 years, Jon Kessler, President and Chief Executive Officer, has decided to retire effective January 6, 2025. Mr. Kessler will remain a director and act a special advisor to the Company through April 30, 2025. To succeed Mr. Kessler, the Company announced the appointment of Scott Cutler, who will join HealthEquity as President and CEO and as a director effective January 6, 2025. HealthEquity management will host a conference call for investors on Tues
DRAPER, Utah, Oct. 30, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced plans to release its third quarter of fiscal 2025 financial results following the close of regular stock market trading hours on Monday, December 9, 2024. Following the news release, HealthEquity management plans to host a conference call for investors on Monday, December 9, 2024, at 4:30 p.m. Eastern Time during which management will review the Company's third quarter results. HealthEquity Third Quarter Fiscal Year 2025 Results Conference CallDate:December 9, 2024Time:4:30 p.m. Eastern Time / 2:30
Highlights of the second quarter include: Revenue of $299.9 million, an increase of 23% compared to $243.5 million in Q2 FY24.Net income of $35.8 million, compared to $10.6 million in Q2 FY24, with non-GAAP net income of $76.3 million, an increase of 67% compared to $45.6 million in Q2 FY24.Net income per diluted share of $0.40, compared to $0.12 in Q2 FY24, with non-GAAP net income per diluted share of $0.86, compared to $0.53 in Q2 FY24.Adjusted EBITDA of $128.3 million, an increase of 46% compared to $88.1 million in Q2 FY24.9.4 million HSAs, an increase of 15% compared to Q2 FY24.Total HSA Assets of $29.5 billion, an increase of 27% compared to Q2 FY24.16.3 million Total Accounts,
8-K - HEALTHEQUITY, INC. (0001428336) (Filer)
144 - HEALTHEQUITY, INC. (0001428336) (Subject)
S-3ASR - HEALTHEQUITY, INC. (0001428336) (Filer)
DRAPER, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY), a leader in health savings accounts (HSAs) and consumer-directed benefits, is proud to announce Chief Marketing Officer Tia Padia has been recognized with the MarCom Visionary CMO Award for her innovative leadership in the category of Individual's Body of Work. This award recognizes Padia's creative vision to develop the HealthEquity Immersion Experience — a project that showcases HealthEquity's deep understanding of the client and member benefits journey through an interactive, immersive event. "This award goes beyond individual recognition, it's a reflection of the tremendous commitment we have at HealthEq
DRAPER, Utah, Nov. 12, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced that after leading the company for more than 15 years, Jon Kessler, President and Chief Executive Officer, has decided to retire effective January 6, 2025. Mr. Kessler will remain a director and act a special advisor to the Company through April 30, 2025. To succeed Mr. Kessler, the Company announced the appointment of Scott Cutler, who will join HealthEquity as President and CEO and as a director effective January 6, 2025. HealthEquity management will host a conference call for investors on Tues
DRAPER, Utah, Oct. 30, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced plans to release its third quarter of fiscal 2025 financial results following the close of regular stock market trading hours on Monday, December 9, 2024. Following the news release, HealthEquity management plans to host a conference call for investors on Monday, December 9, 2024, at 4:30 p.m. Eastern Time during which management will review the Company's third quarter results. HealthEquity Third Quarter Fiscal Year 2025 Results Conference CallDate:December 9, 2024Time:4:30 p.m. Eastern Time / 2:30
Goldman initiated coverage of HealthEquity with a rating of Neutral and set a new price target of $108.00
JMP Securities initiated coverage of HealthEquity with a rating of Mkt Outperform and set a new price target of $101.00
JP Morgan reiterated coverage of HealthEquity with a rating of Overweight and set a new price target of $108.00 from $86.00 previously
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
DRAPER, Utah, Aug. 21, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity"), the leader in health savings accounts (HSAs) and consumer-directed benefits administration, will kick off the second annual HSA WeekTM on August 26. The weeklong event will include a variety of resources to educate workers and companies about HSAs and their potential to improve healthcare savings and financial stability. According to a recent HealthEquity research study, roughly 40% of employees lack confidence in their health plan decisions and more than half wonder at times if they have chosen the right plan for their needs. The good news is that education can help. The study also found th
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") announced today that Evelyn Dilsaver has been appointed to serve as a member of its Board of Directors. "We're thrilled to have Evelyn join our board," said Jason Murray, PACS Chairman and CEO. "She has great experience as an accounting and finance professional, not to mention her work on the boards of several other public companies. She'll bring added perspective and expertise to the board as we work to guide PACS going forward." "I'm excited to join the PACS Board and assist the company in continuing its mission to provide quality skilled nursing care. I look forward to great things ahead for the company," added Ms. Dilsaver. Ms.
Healthcare IT Industry Expert Will Support the Firm's HCIT Strategy Thomas H. Lee Partners, L.P. ("THL"), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm's healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology ("Healthcare IT"), will support the team's efforts in identifying, sourcing, and growing investment opportunities across the healthcare market. "We are very pleased to welcome Paul to THL as a consultant for the firm's healthcare group," said Shahab Vagefi, Managing Director at THL. "THL has had a longs